You have 9 free searches left this month | for more free features.

stimulant

Showing 26 - 50 of 802

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Methamphetamine Abuse Trial in New York (Affect Methamphetamine Treatment Program)

Completed
  • Methamphetamine Abuse
  • Affect Methamphetamine Treatment Program
  • New York, New York
    Affect Therapeutics
Feb 23, 2022

Intellectual Disability, Fragile X Syndrome, Down Syndrome Trial (Methylphenidate Oral Solution)

Not yet recruiting
  • Intellectual Disability
  • +3 more
  • Methylphenidate Oral Solution
  • (no location specified)
Mar 17, 2022

Change in Cognitive Function in Stimulant Users

Recruiting
  • Cognitive Dysfunction
  • +4 more
  • Cognitive Assessment
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 21, 2021

Stimulant Use Trial in Chicago (Methamphetamine, oral tablet)

Recruiting
  • Stimulant Use
  • Chicago, Illinois
    University of Chicago
May 19, 2022

Epilepsy, Depression Trial in Rochester (Vagal nerve stimulant)

Not yet recruiting
  • Epilepsy
  • Depression
  • Vagal nerve stimulant
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 14, 2023

ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant

Not yet recruiting
  • ADHD
  • Autism Spectrum Disorder
  • Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
  • Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
  • Irvine, California
  • +11 more
Jun 14, 2023

Stimulant Abuse, HIV Prevention, Substance Abuse Trial in Miami, Boston (IMPACT, Standard of Care)

Recruiting
  • Stimulant Abuse
  • +2 more
  • IMPACT
  • Standard of Care
  • Miami, Florida
  • +1 more
Nov 10, 2021

Neurofibromatosis Type 1 Trial in Washington (CogmedRM, Mobymax)

Completed
  • Neurofibromatosis Type 1
  • CogmedRM
  • Mobymax
  • Washington, District of Columbia
    Children's National Health System
Mar 2, 2022

Attention Deficit/Hyperactivity Disorder Trial in Boston (SMS Intervention)

Active, not recruiting
  • Attention Deficit/Hyperactivity Disorder
  • SMS Intervention
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 14, 2022

Stimulant Use, MDMA ('Ecstasy'), Social Behavior Trial in Chicago (MDMA, Methamphetamine, oral tablet)

Recruiting
  • Stimulant Use
  • +3 more
  • Chicago, Illinois
    University of Chicago
Oct 20, 2022

Prescription Drug Abuse (Not Dependent), Intentional Misuse Trial in Hartford, San Marcos, Laramie (Web-based presentation,

Recruiting
  • Prescription Drug Abuse (Not Dependent)
  • Intentional Misuse
  • Web-based placebo presentation
  • Web-based simulation active intervention
  • Hartford, Connecticut
  • +2 more
Apr 1, 2022

Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered Trial in Boston (Methylphenidate)

Recruiting
  • Brain Injury Traumatic Severe (Diagnosis)
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 1, 2022

Substance Use Disorders, Alcohol Use Disorder, Stimulant-Related Disorder Trial (Cognitive Behavioral Therapy)

Not yet recruiting
  • Substance Use Disorders
  • +2 more
  • Cognitive Behavioral Therapy
  • (no location specified)
Jul 5, 2023

ADHD Trial in Hershey (CNS Stimulant)

Recruiting
  • ADHD
  • CNS Stimulant
  • Hershey, Pennsylvania
    Penn State Hershey
Jul 18, 2022

Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders, Stimulant Dependence

Recruiting
  • Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)
  • +4 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Aug 17, 2021

Cocaine Dependence Trial in Charlottesville, Richmond (Ondansetron, Placebo)

Completed
  • Cocaine Dependence
  • Charlottesville, Virginia
  • +1 more
Oct 15, 2021

Substance Use Disorders Trial in Seoul (CDP-choline, Placebo, Supportive psychotherapy)

Recruiting
  • Substance Use Disorders
  • Seoul, Korea, Republic of
    Ewha Womans University Mokdong Hospital
Jul 28, 2022

Adherence, Medication, HIV-1-infection, Stimulant Use Trial in Miami (START mHealth Intervention)

Recruiting
  • Adherence, Medication
  • +2 more
  • START mHealth Intervention
  • Miami, Florida
    University of MIami
Jul 25, 2022

Attention Deficit/Hyperactivity Disorder, Initial Insomnia Trial in Edmonton (Melatonin, Placebo)

Withdrawn
  • Attention Deficit/Hyperactivity Disorder
  • Initial Insomnia
  • Melatonin
  • Placebo
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 5, 2021

Breath Test, Oesophageal Cancer, Gastric Cancer Trial in London (Oral Stimulant Drink)

Not yet recruiting
  • Breath Test
  • +4 more
  • Oral Stimulant Drink
  • London, United Kingdom
    Volatile Biomarker Group, Commonwealth Building, Hammersmith Hos
Oct 30, 2022

Methamphetamine Use Disorder, Substance-Related Disorders, Chemically-Induced Disorders Trial in Madison (Psilocybin)

Recruiting
  • Methamphetamine Use Disorder
  • +4 more
  • Madison, Wisconsin
    University of Wisconsin
Jan 9, 2023

Cocaine Dependence, Methamphetamine Dependence, Nicotine Dependence Trial in United States (Smoking-cessation treatment)

Completed
  • Cocaine Dependence
  • +2 more
  • Smoking-cessation treatment
  • Tucson, Arizona
  • +11 more
Sep 27, 2021

Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)

Not yet recruiting
  • Attention Deficit Disorder With Hyperactivity
  • Neurotransmitters evaluation by MRS
  • Kfar Saba, Israel
  • +1 more
Jul 14, 2022

Fetal Alcohol Spectrum Disorders Trial in Clayton (Methylphenidate Hydrochloride, Placebo, Methylphenidate HCl)

Recruiting
  • Fetal Alcohol Spectrum Disorders
  • Methylphenidate Hydrochloride
  • +4 more
  • Clayton, Victoria, Australia
    Monash Health
Feb 22, 2022

Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,

Recruiting
  • Sleep Disorder
  • Healthy
  • Sleep Fragmentation
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Nov 14, 2022